BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 26422992)

  • 1. Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s.
    Tang L; Peng H; Zhou J; Chen Y; Wei H; Sun R; Yokoyama WM; Tian Z
    J Autoimmun; 2016 Feb; 67():29-35. PubMed ID: 26422992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-examining the origin and function of liver-resident NK cells.
    Peng H; Tian Z
    Trends Immunol; 2015 May; 36(5):293-9. PubMed ID: 25846402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLZF expression maps the early stages of ILC1 lineage development.
    Constantinides MG; Gudjonson H; McDonald BD; Ishizuka IE; Verhoef PA; Dinner AR; Bendelac A
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5123-8. PubMed ID: 25838284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation.
    Sudan R; Gilfillan S; Colonna M
    Immunol Rev; 2024 May; 323(1):107-117. PubMed ID: 38563448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 innate lymphoid cells: Soldiers at the front line of immunity.
    Nabekura T; Shibuya A
    Biomed J; 2021 Apr; 44(2):115-122. PubMed ID: 33839081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-resident natural killer cells in the livers.
    Peng H; Tian Z
    Sci China Life Sci; 2016 Dec; 59(12):1218-1223. PubMed ID: 27909848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s.
    Sheppard S; Schuster IS; Andoniou CE; Cocita C; Adejumo T; Kung SKP; Sun JC; Degli-Esposti MA; Guerra N
    Cell Rep; 2018 Mar; 22(13):3385-3392. PubMed ID: 29590608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell RNA sequencing identifies a population of human liver-type ILC1s.
    Krämer B; Nalin AP; Ma F; Eickhoff S; Lutz P; Leonardelli S; Goeser F; Finnemann C; Hack G; Raabe J; ToVinh M; Ahmad S; Hoffmeister C; Kaiser KM; Manekeller S; Branchi V; Bald T; Hölzel M; Hüneburg R; Nischalke HD; Semaan A; Langhans B; Kaczmarek DJ; Benner B; Lordo MR; Kowalski J; Gerhardt A; Timm J; Toma M; Mohr R; Türler A; Charpentier A; van Bremen T; Feldmann G; Sattler A; Kotsch K; Abdallah AT; Strassburg CP; Spengler U; Carson WE; Mundy-Bosse BL; Pellegrini M; O'Sullivan TE; Freud AG; Nattermann J
    Cell Rep; 2023 Jan; 42(1):111937. PubMed ID: 36640314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Regulation of Mouse Tissue-Resident Natural Killer Cell Development.
    Valero-Pacheco N; Beaulieu AM
    Front Immunol; 2020; 11():309. PubMed ID: 32161593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression.
    Turchinovich G; Ganter S; Bärenwaldt A; Finke D
    J Immunol; 2018 Jun; 200(11):3762-3768. PubMed ID: 29661825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches.
    Asahi T; Abe S; Cui G; Shimba A; Nabekura T; Miyachi H; Kitano S; Ohira K; Dijkstra JM; Miyazaki M; Shibuya A; Ohno H; Ikuta K
    Elife; 2023 Jun; 12():. PubMed ID: 37352115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses.
    Picarda G; Ghosh R; McDonald B; Verma S; Thiault N; El Morabiti R; Griffith TS; Benedict CA
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-resident memory-like ILCs: innate counterparts of T
    Wang X; Tian Z; Peng H
    Protein Cell; 2020 Feb; 11(2):85-96. PubMed ID: 31286412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Central Nervous System Contains ILC1s That Differ From NK Cells in the Response to Inflammation.
    Romero-Suárez S; Del Rio Serrato A; Bueno RJ; Brunotte-Strecker D; Stehle C; Figueiredo CA; Hertwig L; Dunay IR; Romagnani C; Infante-Duarte C
    Front Immunol; 2019; 10():2337. PubMed ID: 31649664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells and type 1 innate lymphoid cells: partners in host defense.
    Spits H; Bernink JH; Lanier L
    Nat Immunol; 2016 Jun; 17(7):758-64. PubMed ID: 27328005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILC1s in Tissue Inflammation and Infection.
    Fuchs A
    Front Immunol; 2016; 7():104. PubMed ID: 27047491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements.
    Gabrielli S; Sun M; Bell A; Zook EC; de Pooter RF; Zamai L; Kee BL
    Eur J Immunol; 2017 May; 47(5):800-805. PubMed ID: 28276053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of RORα for maintenance and antitumor immunity of liver-resident natural killer cells/ILC1s.
    Song J; Song H; Wei H; Sun R; Tian Z; Peng H
    Hepatology; 2022 May; 75(5):1181-1193. PubMed ID: 34510508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back to the drawing board: Understanding the complexity of hepatic innate lymphoid cells.
    Marotel M; Hasan U; Viel S; Marçais A; Walzer T
    Eur J Immunol; 2016 Sep; 46(9):2095-8. PubMed ID: 27600673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid receptor activity is required for the maintenance of type 1 innate lymphoid cells.
    Asahi T; Abe S; Tajika Y; Rodewald HR; Sexl V; Takeshima H; Ikuta K
    Int Immunol; 2023 Mar; 35(3):147-155. PubMed ID: 36480702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.